Sintx Technologies (SINT) Cash from Investing Activities (2013 - 2026)
Sintx Technologies (SINT) posted Cash from Investing Activities of -$7000.0 for Q1 2026, up 83.33% on a QoQ basis from -$42000.0 in Q4 2025, and up 88.89% year-over-year from -$3705.9 in Q1 2025.
Powered by 
Analysis
Sintx Technologies (SINT) Cash from Investing Activities (2013 - 2026) Analysis & Trends
Sintx Technologies has reported Cash from Investing Activities for 14 years, with the latest figure at -$7000.0 in Q1 2026.
- On a quarterly basis, Cash from Investing Activities rose 88.89% year-over-year to -$7000.0 in Q1 2026; TTM through Mar 2026 was $969000.0, a 1253.57% increase from a year earlier, with the FY2025 full-year figure at $913000.0, up 570.62% from the prior year.
- Cash from Investing Activities was -$7000.0 for Q1 2026 at Sintx Technologies, up from -$42000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $666000.0 in Q3 2025, with the low at -$510000.0 in Q3 2022.
- Average Cash from Investing Activities over 5 years is -$55625.0, with a median of -$64000.0 recorded in 2022.
- The largest YoY upside for Cash from Investing Activities was 2248.39% in 2025 against a maximum downside of 520.0% in 2025.
- Over 5 years, Cash from Investing Activities stood at -$296000.0 in 2022, then soared by 79.05% to -$62000.0 in 2023, then surged by 116.13% to $10000.0 in 2024, then plunged by 520.0% to -$42000.0 in 2025, then jumped by 83.33% to -$7000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$7000.0 (Q1 2026), -$42000.0 (Q4 2025), and $666000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Sintx Technologies | 8.73 Mn | 8.73 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -7,000.00 |
| Dec 31, 2025 | -42,000.00 |
| Sep 30, 2025 | 666,000.00 |
| Jun 30, 2025 | 352,000.00 |
| Mar 31, 2025 | -63,000.00 |
| Dec 31, 2024 | 10,000.00 |
| Sep 30, 2024 | -31,000.00 |
| Mar 31, 2024 | -173,000.00 |
| Dec 31, 2023 | -62,000.00 |
| Sep 30, 2023 | -105,000.00 |
| Jun 30, 2023 | -98,000.00 |
| Mar 31, 2023 | -236,000.00 |
| Dec 31, 2022 | -296,000.00 |
| Sep 30, 2022 | -510,000.00 |
| Jun 30, 2022 | -65,000.00 |
| Mar 31, 2022 | -230,000.00 |
| Dec 31, 2021 | -534,000.00 |
| Sep 30, 2021 | -2.58 Mn |
| Jun 30, 2021 | 1.06 Mn |
| Mar 31, 2021 | 406,000.00 |